• About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News
Sunday, June 1, 2025
  • Login
National Age
  • Home
  • India
    • National
    • State News
  • World
  • Education
  • Lifestyle
    • Health & Fitness
    • Fashion
    • Travel
    • Food
  • Business
  • Tech
    • App News
    • Gadgets
  • Entertainment
  • Auto
  • Sports
  • Others
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
No Result
View All Result
  • Home
  • India
    • National
    • State News
  • World
  • Education
  • Lifestyle
    • Health & Fitness
    • Fashion
    • Travel
    • Food
  • Business
  • Tech
    • App News
    • Gadgets
  • Entertainment
  • Auto
  • Sports
  • Others
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
No Result
View All Result
National Age
No Result
View All Result
Home Lifestyle Health & Fitness

Researchers identify drug that can be repurposed to treat COVID-19

National Age by National Age
March 22, 2021
in Health & Fitness, Science
0
Researchers identify drug that can be repurposed to treat COVID-19

Dr. Siddappa N. Byrareddy (L) and Dr. Amjad Husain (R)

Share on FacebookShare on Twitter

New Delhi: Currently, there are no universally approved drugs for the treatment of COVID-19. There is a worldwide scramble to find drugs for the ongoing COVID-19 pandemic. Now researchers at the Indian Institute of Science Education and Research (IISER), Bhopal and the University of Nebraska Medical Centre, Nebraska, (UNMC), USA have identified Rapamycinas a potential drug that can be repurposed to treat COVID-19.

Rapamycin used to prevent organ rejection after transplants and in cancer treatment, was found to have anti-aging effect and the potential to treat COVID-19 patients, researchers said. Currently being used for patients having undergone organ transplantation and certain cancer patients, Rapamycin and its analogues are commonly available in India and abroad.

Researchers showed that the biochemical working of this drug molecule points to its promise in the treatment of COVID-19.  The paper elaborates on the rationale of repurposing this drug for treating COVID-19 patients. Since the repurposed drug has gone through the clinical development process for the treatment of other diseases and has already been tested for toxicity, many steps in preclinical and early clinical development can be avoided and the drug can be directly tested on COVID-19 subjects in phase-II trials.

Read ThisAlso

Combining NDT and DMI: A Comprehensive Approach to Developmental Delay

Combining NDT and DMI: A Comprehensive Approach to Developmental Delay

May 28, 2025
As COVID-19 Cases Resurface, Pravek Kalp Promotes Ayurvedic Immunity and Heart Health with Ashwagandha and Arjuna Capsules

As COVID-19 Cases Resurface, Pravek Kalp Promotes Ayurvedic Immunity and Heart Health with Ashwagandha and Arjuna Capsules

May 27, 2025

This study was jointly conducted by Dr. Amjad Husain, Principal Scientist, and Chief Executive Officer, Innovation and Incubation Center for Entrepreneurship (IICE), IISER Bhopal, and Dr. Siddappa N. Byrareddy, Associate Professor, Pharmacology, and Vice-Chair, Research at UNMC, USA. Research findings were recently published in a peer-reviewed journal, Chemico Biological Interactions.

Elaborating on the importance of this finding, Dr. Amjad Husain, Principal Scientist, and Chief Executive Officer, Innovation and Incubation Center for Entrepreneurship (IICE), IISER Bhopal, said, “The development of a new drug is time-consuming and cannot be relied on as a solution in combating the immediate pandemic. Drug repurposing is an attractive solution, wherein, an existing drug used to treat another related or unrelated ailment may be tested against COVID-19.”

An example of such a repurposed drug is Remdesivir. It was originally developed to treat Hepatitis C infection. The drug has shown limited success in treating COVID-19 patients.  Identification of more such drugs is important given the scale of the pandemic. Rapamycin works differently from Remdesivir. While the latter targets the virus itself, this Rapamycin targets the host proteins and may resist the infection.

“Using repurposed drug such as Rapamycin that targets mTOR, a central molecule affecting multiple signalling pathways, may yield a significant clinical benefit for the treatment of COVID-19” added Dr. Husain.

One of the main challenges in developing antiviral drugs for COVID-19 has been the extensive mutations that the virus undergoes, which makes one antiviral drug ineffective against another mutant, and the development of drug-resistant strains. Treatment with drugs such as Rapamycin will not face that problem because it acts on host proteins and not on the virus. Rapamycin inhibits protein synthesis and can also arrest virus replication, irrespective of the type of mutant.

At a biochemical level, apart from inhibiting protein synthesis, Rapamycin has been known to inhibit pro-inflammatory cytokines. It is known that severe COVID-19 infection results in an increase in inflammatory cytokines in a process known as the ‘cytokine storm’. The inhibitory action of Rapamycin towards cytokines also makes it a promising treatment for COVID-19.

Besides, Rapamycin is known to reduce obesity through various pathways and this can help in mitigating the severity of COVID-19 effects in obese people.

Furthermore, Rapamycin is known to induce autophagy, a cellular recycling process that helps in eliminating the damaged proteins and delaying aging.  Given the connection between age and COVID mortality, i.e. more fatalities with older people, the anti-aging properties of Rapamycin can have protective effects against COVID-10-induced morbidities. (India Science Wire)

Tags: coronavirusCOVID-19Drug repurposingResearch & Development
Share6Tweet4Share1SendShareSend
Previous Post

Dietician and Detox expert urges everyone to take fitness on priority

Next Post

Eco-friendly scooter for last mile delivery and personal commute

National Age

National Age

Related Posts

Combining NDT and DMI: A Comprehensive Approach to Developmental Delay
Health & Fitness

Combining NDT and DMI: A Comprehensive Approach to Developmental Delay

May 28, 2025
As COVID-19 Cases Resurface, Pravek Kalp Promotes Ayurvedic Immunity and Heart Health with Ashwagandha and Arjuna Capsules
Health & Fitness

As COVID-19 Cases Resurface, Pravek Kalp Promotes Ayurvedic Immunity and Heart Health with Ashwagandha and Arjuna Capsules

May 27, 2025
Global aesthetic thought leader shares innovations at milestone SIME 2025 event in Italy
Health & Fitness

Global aesthetic thought leader shares innovations at milestone SIME 2025 event in Italy

May 23, 2025
Aarogyaa Bharat: The Pune-Based Startup Revolutionizing Access to Medical Equipment Across India
Health & Fitness

Aarogyaa Bharat: The Pune-Based Startup Revolutionizing Access to Medical Equipment Across India

May 21, 2025
Invisalign Treatment Delivers Predictable Results for Adult Patients, Achieving Complete Space Closure in as Little as 8 Months
Health & Fitness

Invisalign Treatment Delivers Predictable Results for Adult Patients, Achieving Complete Space Closure in as Little as 8 Months

May 20, 2025
Dr. Vikas Sharma (LaghaV) – Winner of the 21st Century Emily Dickinson Award
Health & Fitness

Dr. Vikas Sharma (LaghaV) – Winner of the 21st Century Emily Dickinson Award

May 17, 2025
Next Post
Eco-friendly scooter for last mile delivery and personal commute

Eco-friendly scooter for last mile delivery and personal commute

Gautam Khaitan has called National Policy on migrant labour essential for the overall development of the nation.

Pandemic exposed the dire need of national policy on migrants, says Gautam Khaitan

CSIR-CMERI transfers COVID related technologies for commercial production

CSIR-CMERI transfers COVID related technologies for commercial production

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Trending
  • Comments
  • Latest
Pro Cricket Championship Trophy (PCCT) announced the schedule of their selection trials and matches today

Pro Cricket Championship Trophy (PCCT) announced the schedule of their selection trials and matches today

May 26, 2022
Now our E-store India has become an international company

Now our E-store India has become an international company

November 1, 2022
Rotary announces: 20th Global Poster Painting Competition

Rotary announces: 20th Global Poster Painting Competition

June 8, 2022
On 27th & 28th December at Surat Marriott, Athwalines India’s premier fashion showcase Hi Life Exhibition is back

On 27th & 28th December at Surat Marriott, Athwalines India’s premier fashion showcase Hi Life Exhibition is back

December 26, 2023

Changa Video sharing app crosses 2 million on play store

0

World’s first DeepUV Air Sanitizer, launched by Indian startup Dokat Inc.

0

Japan’s tech start-ups bitgrit and Atrae rolls out professional ‘matching’ app in India offering jobs in India

0

Surat’s company invents – low-cost,high-end ventilator in support of the Aatmanirbhar Bharat Abhiyan

0
TCL Q6 Series: The Real Deal for Tech-Savvy TV Buyers This Year? (Yeah, We’re Looking Closely!)

TCL Q6 Series: The Real Deal for Tech-Savvy TV Buyers This Year? (Yeah, We’re Looking Closely!)

May 30, 2025
Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

May 30, 2025
Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

May 29, 2025
Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

May 28, 2025

Recent News

TCL Q6 Series: The Real Deal for Tech-Savvy TV Buyers This Year? (Yeah, We’re Looking Closely!)

TCL Q6 Series: The Real Deal for Tech-Savvy TV Buyers This Year? (Yeah, We’re Looking Closely!)

May 30, 2025
Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

May 30, 2025
Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

May 29, 2025
Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

May 28, 2025

www.nationalage.com, digital news and story platform bring you the news, articles, stories, and opinions on the latest happenings worldwide covering various sectors like nation, politics, and governance, social sector, review, foreign affairs, defence and security, latest review, lifestyle, entertainment, sports, technology, auto sectors, education, business and start-ups updates, Agriculture, Science, finance, money, food, and culture, etc.

If you have any query regarding Site, Advertisement, and any other issue, please feel free to contact at [email protected]

Follow Us

Browse by Category

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion
  • Finance/Money
  • Food
  • Gadgets
  • Health & Fitness
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • Uncategorized
  • World
TCL Q6 Series: The Real Deal for Tech-Savvy TV Buyers This Year? (Yeah, We’re Looking Closely!)

TCL Q6 Series: The Real Deal for Tech-Savvy TV Buyers This Year? (Yeah, We’re Looking Closely!)

May 30, 2025
Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

May 30, 2025
Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

May 29, 2025
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News

Copyright © 2021 National Age

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

Copyright © 2021 National Age

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In